ETF Trends
is now
VettaFi.
Read More >
Expert Insights
ETF Channels
ETF Strategist
ETF Building Blocks
Active ETF
ETF Education
Alternatives
Fixed Income
Beyond Basic Beta
Future ETFs
China Insights
Gold & Silver Investing
Climate Insights
Innovative ETFs
Commodities
Institutional Income Strategies
Core Strategies
Leveraged & Inverse
Crypto
Managed Futures
Disruptive Technology
Modern Alpha
Dividend
Multi-Asset
Dual Impact
Multi-Factor
Emerging Markets
Nasdaq Investment Intelligence
Energy Infrastructure
Portfolio Strategies
Entrepreneur ETF
Retirement Income
Equity ETF
Smart Beta
ESG
Thematic Investing
Volatility Resource
Webcasts
Popular ETFs
SPY – SPDR S&P 500 ETF
VOO – Vanguard S&P 500 ETF
QQQ – Invesco QQQ ETF
GLD – SPDR Gold Shares ETF
IVV – iShares Core S&P 500 ETF
EFA – iShares MSCI EAFE ETF
EEM – iShares MSCI Emerging Markets ETF
IEMG – iShares Core MSCI Emerging Markets ETF
VTI – Vanguard Total Stock Market ETF
GDX – VanEck Vectors Gold Miners ETF
XLF – Financial Select Sector SPDR Fund
VEA – Vanguard FTSE Developed Markets ETF
VTV – Vanguard Value ETF
Top Gold ETFs
Top Oil ETFs
Top Commodity ETFs
Top Hedge Fund ETFs
Top Financials ETFs
Top Inverse Equities ETFs
Top High Yield Bond ETFs
ETF Education
First Bitcoin ETF
Newsletter
New ETFs
ETF Ecosystem
Education Central
ETF Playbook
ETFinTwit
Videos & Podcasts
Videos
ETF of the Week
ETF Prime Podcast
ETF 360 Video Series
Podcasts
Events
Exchange: An ETF Experience
ETFs Future-Forward 2021: An iShares Investing Symposium
PBE
Featured
Big Biotech ETF Still in Uptrend…For Now
By
Tom Lydon
March 26, 2014
Featured
Health Care ETFs Raking in Plenty of Cash
By
Todd Shriber
March 6, 2014
Featured
Why This Biotech ETF Leads the Pack
By
Todd Shriber
February 21, 2014
Equity ETFs
Health Care Heaven: Sector’s ETFs Flex Their Muscles
By
Todd Shriber
February 14, 2014
Featured
The One ETF Really Benefiting From the Intercept Pharma News
By
Todd Shriber
January 9, 2014
Featured
Intense Duel to be 2013’s Best Health Care ETF
By
Tom Lydon
December 23, 2013
Featured
Biotech ETFs: More Tricks Than Treats in October
By
Max Chen
October 31, 2013
Featured
Sell-Off in Biotech ETFs Could Be a Temporary Setback
By
Tom Lydon
October 10, 2013
Featured
10 ETF Investments That Got the Most Bang for Your Buck
By
Tom Lydon
October 8, 2013
Featured
Three ETFs to Play Up-and-Coming Health Care Companies
By
Tom Lydon
September 3, 2013
Featured
Three ETFs to Play the Outperforming Biotech Sector
By
Tom Lydon
August 19, 2013
Featured
Choosing the Right Biotech ETF Exposure
By
Tom Lydon
April 20, 2012
Featured
Biotech ETFs Mixed After Gilead Subpoena
By
Tom Lydon
June 13, 2011
Featured
5 Biotechnology ETFs to Play Innovation
By
Tom Lydon
February 22, 2011
Featured
Why Health Care ETFs May Be In the Clear
By
Tom Lydon
November 10, 2010
Featured
5 Things That Drive Biotech ETFs
By
Tom Lydon
October 21, 2010
Featured
Biotech ETFs:The Better Way to Play
By
Tom Lydon
October 11, 2010
Featured
Biotech ETFs: 5 Ways to Play Innovation
By
Tom Lydon
August 8, 2010
Previous
1
2
3
4
Next
X